Cargando…
Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
The COVID-19 pandemic caused by SARS-CoV-2 remains a global public health threat and has prompted the development of antiviral therapies. Artificial intelligence may be one of the strategies to facilitate drug development for emerging and re-emerging diseases. The main protease (M(pro)) of SARS-CoV-...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143255/ https://www.ncbi.nlm.nih.gov/pubmed/37112871 http://dx.doi.org/10.3390/v15040891 |